Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 799 (ZNF799) is a member of the zinc finger protein family, characterized by the presence of C2H2-type zinc finger domains that mediate sequence-specific DNA binding. ZNF799 functions as a putative transcription factor, participating in the regulation of gene expression by binding to RNA polymerase II regulatory regions and interacting with zinc ions[4][5]. There is no evidence it acts as a therapeutic target, biomarker, or disease-associated factor based on current available data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 799 (ZNF799).